The aims of this study were to determine the prevalence of glucose-6-phosph
ate dehydrogenase (G6PD) deficiency in the United Arab Emirates (UAE), to d
escribe the different mutations in the population, to determine its prevale
nce, and to study inheritance patterns in families of G6PD-deficient indivi
duals. All infants born at Tawam Hospital, Al-Ain, UAE from January 1994 to
September 1996 were screened at birth for their G6PD status. In addition,
those attending well-baby clinics during the period were also screened for
the disorder. Families of 40 known G6PD-deficient individuals, selected ran
domly from the records of three hospitals in the country, were assessed for
G6PD deficiency. Where appropriate, this was followed by definition of G6P
D mutations. Of 8198 infants, 746 (9.1%), comprising 15% of males and 5% of
females tested, were found to be G6PD deficient. A total of 27 families we
re further assessed: of these, all but one family had the nt563 Mediterrane
an mutation. In one family, two individuals had the nt202 African mutation.
The high manifestation of G6PD deficiency in women may be due to the prefe
rential expression of the G6PD-deficient gene and X-inactivation of the nor
mal gene, and/or to the presence of an 'enhancer' gene that makes the expre
ssion of the G6PD deficiency more likely. The high level of consanguinity w
hich, theoretically, should result in a high proportion of homozygotes and
consequently a higher proportion of females with the deficiency, was not fo
und to be a significant factor.